Beranda › Penyakit Sel Sabit › Alabama › Birmingham
Uji klinis Penyakit Sel Sabit di Birmingham, AL
14 studi untuk Penyakit Sel Sabit mencari peserta di lokasi sekitar Birmingham (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Menerima pesertaFase 3
- University Of Alabama, Birmingham
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
Menerima pesertaFase 1
- University of Alabama at Birmingham, Birmingham
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Menerima pesertaFase 3
- Uni of Alabama at Birmingham, Birmingham
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Menerima pesertaFase 1/2Sukarelawan sehat diterima
- University of Alabama Birmingham, Birmingham
SCD Stem Cell Mobilization and Apheresis Using Motixafortide
Menerima pesertaFase 1
- University of Alabama at Birmingham, Birmingham
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
Menerima pesertaFase 1/2Sukarelawan sehat diterima
- University of Alabama at Birmingham, Birmingham
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
Menerima pesertaFase 3
- University of Alabama at Birmingham- Site Number : 8400003, Birmingham
Early Life Exposures Among Children With Sickle Cell Disease
Menerima peserta
- University of Alabama at Birmingham, Birmingham
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
Menerima pesertaFase 4
- University Of Alabama, Birmingham
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
Menerima pesertaStudi observasional
- Children's of Alabama (MRD-HCT), Birmingham
- Children's of Alabama (NT-DMT), Birmingham
Cognitive Remediation Intervention to Prepare for Transition of Care
Menerima pesertaFase 2
- University of Alabama at Birmingham, Birmingham
A Long-term Follow-up Study in Patients Who Received BEAM-101
Menerima pesertaStudi observasional
- University of Alabama at Birmingham, Birmingham
HPC Offered for PRESERVE Expansion
Menerima pesertaStudi observasional
- University of Alabama, Birmingham, Birmingham
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
Menerima pesertaStudi observasional
- University of Alabama, Birmingham (UAB), Birmingham
Uji klinis Penyakit Sel Sabit di kota lain
- Atlanta, GA22 studi
- Washington, DC20 studi
- Memphis, TN18 studi
- Chicago, IL18 studi
- Philadelphia, PA15 studi
- New York City, NY13 studi
- St. Louis, MO12 studi
- Durham, NC10 studi
- Cincinnati, OH10 studi
- Boston, MA10 studi
- Houston, TX10 studi
- Pittsburgh, PA9 studi
Studi lain di Birmingham
- Kanker (semua jenis)30 studi
- Kanker Payudara24 studi
- Obesitas23 studi
- Kanker Ovarium23 studi
- Kanker Paru Non-Sel Kecil22 studi
- Leukemia Mieloid Akut21 studi
- Mieloma Multipel18 studi
- PPOK17 studi
- Penyakit Kardiovaskular17 studi
- Kelebihan Berat Badan16 studi
- Kanker Endometrium16 studi
- Diabetes Tipe 216 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.